<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Patterson Gentile C</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><funding>Pfizer</funding><funding>NINDS NIH HHS</funding><funding>National Institute of Neurological Disorders and Stroke (NINDS)</funding><pagination>1217-1229</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11560481</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>64(10)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>We used Cluster Analysis of Migraine-associated Symptoms (CAMS) to critically evaluate current International Classification of Headache Disorders-Third Edition (ICHD-3) migraine-associated symptoms criteria.&lt;h4>Background&lt;/h4>Diagnostic criteria play a central role in guiding clinical trial inclusion, and therefore available treatments. Migraine and tension-type headaches (TTH) are differentiated in ICHD-3 by many headache characteristics, including associated symptoms. A diagnosis of probable migraine indicates some but not all features of migraine are met. Photophobia and phonophobia, or nausea and/or vomiting, are required to meet a diagnosis of migraine; however, CAMS-a model that describes associated symptoms across youth with headache-indicates that a broader range</pubmed_abstract><journal>Headache</journal><pubmed_title>A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross-sectional headache registry study in youth.</pubmed_title><pmcid>PMC11560481</pmcid><funding_grant_id>K23 NS124986</funding_grant_id><funding_grant_id>K23NS102521</funding_grant_id><funding_grant_id>K23NS124986</funding_grant_id><funding_grant_id>K23 NS102521</funding_grant_id><pubmed_authors>Szperka CL</pubmed_authors><pubmed_authors>Hershey AD</pubmed_authors><pubmed_authors>Patterson Gentile C</pubmed_authors></additional><is_claimable>false</is_claimable><name>A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross-sectional headache registry study in youth.</name><description>&lt;h4>Objectives&lt;/h4>We used Cluster Analysis of Migraine-associated Symptoms (CAMS) to critically evaluate current International Classification of Headache Disorders-Third Edition (ICHD-3) migraine-associated symptoms criteria.&lt;h4>Background&lt;/h4>Diagnostic criteria play a central role in guiding clinical trial inclusion, and therefore available treatments. Migraine and tension-type headaches (TTH) are differentiated in ICHD-3 by many headache characteristics, including associated symptoms. A diagnosis of probable migraine indicates some but not all features of migraine are met. Photophobia and phonophobia, or nausea and/or vomiting, are required to meet a diagnosis of migraine; however, CAMS-a model that describes associated symptoms across youth with headache-indicates that a broader range</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov-Dec</publication><modification>2026-06-05T07:17:24.352Z</modification><creation>2026-05-14T03:08:35.04Z</creation></dates><accession>S-EPMC11560481</accession><cross_references><pubmed>39463026</pubmed><doi>10.1111/head.14858</doi></cross_references></HashMap>